The eagerly awaited EMJ Interventional Cardiology 6.1, offering a comprehensive and independent review of EuroPCR 2018, is now available for all to enjoy.

The symposium was a practical, case-based discussion in which four panellists each presented a real and challenging case regarding dual antiplatelet…

ST-segment elevation myocardial infarction (STEMI) can represent a suitable scenario for the use of bioresorbable vascular scaffold technologies because…

Nearly 11,000 participants from all over the world arrived at the heart of Paris, France for EuroPCR 2018. Torrential rain failed to put a dampener…

The everolimus-eluting bioresorbable stent (BRS) Absorb BVS® (Abbott Vascular, Chicago, Illinois, USA), which is still considered the most widely…

This year was my first time attending EuroPCR. Fresh-faced and optimistic, I was part of a delegation sent by the EMJ to absorb every ounce of wisdom…

There is some controversy regarding left ventricular ejection fraction (LVEF) improvement after chronic total occlusion (CTO) recanalisation. While a…

During the EuroPCR 2018 Congress, we sat down with EMJ Interventional Cardiology Editorial Board member Dr Pablo Sepúlveda Varela to learn more about…

This year’s spectacular EuroPCR Congress saw many reasons to celebrate, including both pioneering research from the field and personal achievements…